Panacea Biotec531349Board meeting scheduled
Board meeting on November 14, 2026 to approve unaudited results for quarter and half year ended September 30, 2026
Panacea Biotec's Board of Directors meets on Saturday, November 14, 2026, at New Delhi.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Saturday, November 14, 2026, at New Delhi
- Agenda
- Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and half year ended September 30, 2026
- Trading Window Closure
- October 01, 2026 till November 16, 2026
A scheduled Board meeting has been announced, and the main item on the table is the company's quarterly numbers.
What the company has told the exchanges
- The Board of Directors of Panacea Biotec is scheduled to meet on Saturday, November 14, 2026, at New Delhi.
- The meeting will, inter-alia, consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and half year ended September 30, 2026.
- Notice of the meeting is also being uploaded on the company's website.
- The trading window of the company shall remain closed for all Designated Persons (including their Immediate Relatives) from October 01, 2026 till November 16, 2026. This follows the company's earlier announcement dated September 26, 2026 on closure of the trading window.
Why this matters to a retail investor
- This is the standard advance notice a listed company gives before its quarterly results are taken up by the Board. It tells you when the numbers for the September 2026 quarter and the six months ended September 30, 2026 are expected to be considered and approved.
- Until the results are approved and released, the company has not shared any financial figures in this update. The numbers themselves will come separately.
What the trading window closure means
- A trading window is the period during which people who are likely to have advance information about the company — called Designated Persons — are not allowed to buy or sell the company's shares.
- Here it stays closed from October 01, 2026 till November 16, 2026, which covers the run-up to the Board meeting and the days immediately around it. Immediate Relatives of these persons are covered too.
- This restriction applies to those Designated Persons. It does not, by itself, change anything about the company's business or finances.
What to watch for
- The Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and half year ended September 30, 2026, once the Board approves them.
- Any other decisions taken at the November 14, 2026 Board meeting, which will be communicated separately.
Also from Panacea Biotec
1,000 shares dematerialised in September 2026; total demat holding at 6,11,09,526 shares
7 Oct 2026
Two Income Tax Demand Orders Aggregating ~₹4.32 Crore Received; Company to File Appeal
29 Sep 2026
Four Income Tax Demand Orders Imposing Penalty of ~₹9.82 Crore Received
26 Sep 2026
Source: BSE · 5 Nov 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.